Tokyo, Jan. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060308) titled 'Effect of Immune Checkpoint Inhibitors on the renal function in older adults' on Jan. 9.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Metropolitan Insititute for Geriatirics and Gerontology
Condition:
Condition - cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Renal effects of ICIs in cancer patients
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients using immune checkpoint inhibitors
Key exclusion criteria - Patients who are deemed inappropriate
Target Size - 100
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2023 Year 10 Month 12 Day
Date of IRB - 2023 Year 10 Month 12 Day
Anticipated trial start date - 2023 Year 10 Month 12 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068985
Disclaimer: Curated by HT Syndication.
